Buy now (tactical buy): Trend is bullish (SMA_5 > SMA_20 > SMA_200) with MACD strengthening, and pre-market price (21.76) is pressing the near-term breakout level.
Immediate levels matter: Price is sitting right under R1=21.773; a clean push through that level opens room toward R2=22.12.
Not a “deep value” entry: RSI(6)=68.5 is close to overbought and the pattern-based stats show mild near-term chop/weakness (next week bias negative), but the primary trend remains up.
Momentum: MACD histogram +0.129 and expanding = momentum improving.
RSI: RSI_6 68.48 = strong but nearing overbought; upside is possible but entry is not “cheap.”
Key levels:
Pivot 21.212 (line-in-the-sand support)
Resistance: 21.773 (R1) then 22.12 (R2)
Support: 20.65 (S1) then 20.303 (S2)
Quant pattern read: Similar-pattern projection shows slight short-term softness (next week -1.78%) but positive 1-month skew (+2.9%), consistent with an uptrend that can dip before continuing.
Options Data
Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning (Open Interest PCR 1.56): Put open interest exceeds calls (1694 puts vs 1088 calls) = more downside hedging / cautious sentiment among holders.
Flow (Volume PCR 0.62): More call volume than put volume today (79 calls vs 49 puts) = near-term trading flow is more bullish.
Volatility: IV (18.45) below HV (22.07) and very low IV percentile (~0.4) = options priced relatively cheaply; the market is not pricing a major near-term shock.
Activity: Today’s volume is elevated vs recent averages, suggesting increased attention around current levels.
Technical Summary
Sell
0
Buy
10
Positive Catalysts
No negative news overhang (no major adverse headlines in the past week).
Neutral/Negative Catalysts
signals meaningful investor protection against downside.
No event-driven catalyst identified in the last week to force an immediate rerating.
Overall: fundamentals support the prevailing uptrend, even if the entry is not at a discount.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
2025-12-12 (Grupo Santander): Downgraded to Neutral from Outperform; PT MXN 22.
2025-12-11 (BofA): Reinstated at Neutral; PT $26; noted strong 2025 performance (+33% YTD) but 2026 earnings revisions -13% YTD, framing current valuation as fair.
Wall Street pros: Strong 2025 execution/price action and improving financials.
Wall Street cons: Expectations/forward revisions have weakened and analysts see a more balanced risk-reward after the run-up.
Wall Street analysts forecast AMX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMX is 23.38 USD with a low forecast of 19.5 USD and a high forecast of 26 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast AMX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMX is 23.38 USD with a low forecast of 19.5 USD and a high forecast of 26 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
4 Hold
0 Sell
Hold
Current: 21.280
Low
19.5
Averages
23.38
High
26
Current: 21.280
Low
19.5
Averages
23.38
High
26
Grupo Santander
Outperform -> Neutral
downgrade
$22
AI Analysis
2025-12-12
Reason
Grupo Santander
Price Target
$22
AI Analysis
2025-12-12
downgrade
Outperform -> Neutral
Reason
Grupo Santander downgraded America Movil to Neutral from Outperform with a MXN 22 price target.
BofA
Rogerio Araujo
Neutral
maintain
$26
2025-12-11
Reason
BofA
Rogerio Araujo
Price Target
$26
2025-12-11
maintain
Neutral
Reason
BofA analyst Rogerio Araujo reinstated coverage of America Movil with a Neutral rating and $26 price target. The stock outperformed in 2025 with 33% total return year-to-date, while earnings revisions for 2026 dropped 13% year-to-date, notes the analyst, who sees the stock trading at "a fair risk-return."
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AMX
